MrMed
PrivateLast Round
Seed
Aug 30, 2023
Total Funding Raised
$500,000
Momentum Score
25 /100
Company Overview
MrMed is an online pharmacy based in Chennai, India, that operates as one of the country's largest platforms for super-specialty medicines. Founded in 2021, the company aims to make life-saving treatments for critical conditions like cancer, kidney disease, and heart disorders more accessible and affordable across India. In addition to delivering medications, MrMed provides patient-centric services, including assistance with Patient Assistance Programs (PAPs). The company has expanded its presence with dispatch hubs in other cities and a physical retail store in Chennai.
Sector
Healthcare & Life Sciences
Verticals
E-commerce, Pharma Supply Chain, Patient Engagement, Retail Technology
Business Model
B2C
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MrMed Comps
Public and private peers based on sector, stage, and business model.
MrMed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 30, 2023 |
Key People
Founding team and executive leadership
MrMed Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MrMed's valuation, stock price, and market status.